SCORE only predicted four deaths and the difference was not statistically significant (odds ratio, OR 2.3, 95% CI 0.7 to 7.8, P = 0.25). Several parameters measured at baseline differed between deceased and surviving patients (Table 2) and persisted after age adjustment for all outcomes. Established arterial disease and Cystatin C were the strongest risk factors in all groups (Table 3) and were retained in the remaining analyses (Table 4). OM was predicted by several inflammatory parameters, sVCAM-1 and SLICC >1. Smoking was the only traditional risk factor predicting CVM. sVCAM-1, hsCRP, ab2GP1, any aPL at medium titer, and baseline warfarin treatment also predicted CVM. N-VM was positively associated with markers of systemic inflammation and SLICC >1, while SSB autoantibodies were inversely associated (Table 4). Results were similar among women, with a few exceptions (see Table 5).